Liraglutide for patients with non-alcoholic steatohepatitis - Authors' reply.
National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham B15 2TT, UK. Electronic address: p.n.newsome@bham.ac.uk.
Philip N
PN
Newsome
National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham B15 2TT, UK.
Matthew J
MJ
Armstrong
NIHR Birmingham Liver Biomedical Research Unit Clinical Trial Group, CRUK Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK.
Piers
P
Gaunt
D005260:Female; D006801:Humans; D054795:Incretins / Q000008:administration & dosage*; D000069450:Liraglutide / Q000008:administration & dosage*; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*
D054795:Incretins; D000069450:Liraglutide